Supplementary Data 1. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Supplementary Data 1. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer2024
2. 2Supplementary Figure 3. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer2024
3. 3Supplementary Figure 3. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer2024
4. 4Supplementary Data 2. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer2024
5. 5Supplementary Data 2. from The genomic and epigenomic landscape of double-negative metastatic prostate cancer2024